The World Health Organization’s (WHO) Global TB Programme welcomes the results from an important study on shortened treatment for drug-susceptible tuberculosis (TB) in children, presented at the 51st virtual Union World Conference on Lung Health. The study, named SHINE (Shorter Treatment for Minimal Tuberculosis in Children), was sponsored by University College London (UCL), coordinated by the Medical Research Council Clinical Trials Unit at UCL, and funded by the Joint Global Health Trials Scheme of the Department for International Development, the UK Department of Health and Social Care, the Wellcome Trust, and the Medical Research Council, with additional support from the TB Alliance.The
Hence then, the article about shine trial on shorter treatment for children with minimal tb was published today ( ) and is available onWorld Health Organization ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( SHINE trial on shorter treatment for children with minimal TB )